Literature DB >> 24993492

Development of a bronchospasm device model.

Asumi Sugiura1, Kaneyuki Kawamae.   

Abstract

There is no strong evidence to support ventilatory management for critical limitation of expiratory flow, such as bronchospasm during anesthesia or an acute exacerbation of severe asthma and chronic obstructive pulmonary disease (COPD). Animal models cannot be used to develop reproducible experimental models for conducting mechanical ventilation strategy research relating to these etiologies due to the resulting respiratory and hemodynamic instabilities. Therefore, we developed a device model by modifying a positive end-expiratory pressure (PEEP) valve that can simulate the characteristics of airway bronchoconstriction (i.e., limited peak expiratory flow and a prolonged expiratory phase). These characteristics were found to improve upon narrowing the expiratory port. We believe that this device model will facilitate future mechanical ventilation experiments.

Entities:  

Mesh:

Year:  2014        PMID: 24993492     DOI: 10.1007/s00540-014-1872-0

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  4 in total

Review 1.  Management of mechanical ventilation in acute severe asthma: practical aspects.

Authors:  Mauro Oddo; François Feihl; Marie-Denise Schaller; Claude Perret
Journal:  Intensive Care Med       Date:  2006-01-27       Impact factor: 17.440

2.  The mechanism of increase in total lung capacity during acute asthma.

Authors:  L Peress; G Sybrecht; P T Macklem
Journal:  Am J Med       Date:  1976-08       Impact factor: 4.965

Review 3.  Auto-positive end-expiratory pressure and dynamic hyperinflation.

Authors:  V M Ranieri; S Grasso; T Fiore; R Giuliani
Journal:  Clin Chest Med       Date:  1996-09       Impact factor: 2.878

Review 4.  Mouse models of allergic asthma: acute and chronic allergen challenge.

Authors:  Anthony T Nials; Sorif Uddin
Journal:  Dis Model Mech       Date:  2008 Nov-Dec       Impact factor: 5.758

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.